Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2012

Open Access 01-06-2012 | Research article

A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis

Authors: Angela Ceribelli, Minoru Satoh, Edward KL Chan

Published in: Arthritis Research & Therapy | Issue 3/2012

Login to get access

Abstract

Introduction

Classic anti-nucleolar antibodies anti-Th/To and U3 ribonucleoprotein (-U3RNP) can help in the diagnosis, prediction of organ involvement and prognosis in systemic sclerosis (SSc); however, no validated commercial assay is available. We aimed at establishing a novel quantitative real time PCR (qPCR) method to detect these antibodies.

Methods

Standard immunoprecipitation (IP) was performed using K562 cell extract and RNA components were extracted. cDNA was reverse transcribed from RNA components and Th RNA and U3 RNA were detected by qPCR using custom primers. Cycle threshold (Ct) values were compared in a titration experiment to determine the assay efficacy. The new assay was evaluated by testing 22 anti-Th/To and 12 anti-U3RNP positive samples in addition to 88 controls, and the results were compared with IP as a gold standard.

Results

By testing serial 1:8 dilutions of cell lysate as the substrate in the IP step, RNA extracted after IP, and its derived cDNA, linear dose response curves were noted for both anti-Th/To and -U3RNP. With every dilution, Ct values changed approximately three as expected, reflecting the eight-fold difference of cDNA. The Ct difference between positive and negative samples was 8 to 13, which was similar throughout the dilutions. In the specificity analysis, the Ct values of positive samples were clearly different from the negative groups and the results by qPCR had a near perfect correlation with IP.

Conclusions

Our new method readily detects these two clinically important antibodies in SSc. Making tests for anti-Th/To and -U3RNP antibodies widely available to clinicians should be helpful in the diagnosis and follow-up of SSc patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Steen VD: Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005, 35: 35-42. 10.1016/j.semarthrit.2005.03.005.CrossRefPubMed Steen VD: Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005, 35: 35-42. 10.1016/j.semarthrit.2005.03.005.CrossRefPubMed
2.
go back to reference von Muhlen CA, Tan EM: Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995, 24: 323-358. 10.1016/S0049-0172(95)80004-2.CrossRefPubMed von Muhlen CA, Tan EM: Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995, 24: 323-358. 10.1016/S0049-0172(95)80004-2.CrossRefPubMed
3.
go back to reference Hamaguchi Y: Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010, 37: 42-53.CrossRefPubMed Hamaguchi Y: Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010, 37: 42-53.CrossRefPubMed
4.
go back to reference Koenig M, Dieude M, Senecal JL: Predictive value of antinuclear autoantibodies: The lessons of the systemic sclerosis autoantibodies. Autoimmun Rev. 2008, 7: 588-593. 10.1016/j.autrev.2008.06.010.CrossRefPubMed Koenig M, Dieude M, Senecal JL: Predictive value of antinuclear autoantibodies: The lessons of the systemic sclerosis autoantibodies. Autoimmun Rev. 2008, 7: 588-593. 10.1016/j.autrev.2008.06.010.CrossRefPubMed
5.
go back to reference Grassegger A, Pohla-Gubo G, Frauscher M, Hintner H: Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis. Wien Med Wochenschr. 2008, 158: 19-28. 10.1007/s10354-007-0451-5.CrossRefPubMed Grassegger A, Pohla-Gubo G, Frauscher M, Hintner H: Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis. Wien Med Wochenschr. 2008, 158: 19-28. 10.1007/s10354-007-0451-5.CrossRefPubMed
6.
go back to reference Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA: Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum. 2005, 52: 2425-2432. 10.1002/art.21232.CrossRefPubMed Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA: Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum. 2005, 52: 2425-2432. 10.1002/art.21232.CrossRefPubMed
7.
go back to reference Satoh M, Vazquez-Del Mercado M, Chan EKL: Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol. 2009, 19: 219-228. 10.1007/s10165-009-0155-3.PubMedCentralCrossRefPubMed Satoh M, Vazquez-Del Mercado M, Chan EKL: Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol. 2009, 19: 219-228. 10.1007/s10165-009-0155-3.PubMedCentralCrossRefPubMed
8.
go back to reference Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T, Goto D, Takahashi K, Takahashi H, Misaki Y, Mimori T, Muro Y, Yazawa N, Sato S, Takehara K, Kuwana M: Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. Rheumatology (Oxford). 2009, 48: 1570-1574. 10.1093/rheumatology/kep290.CrossRef Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T, Goto D, Takahashi K, Takahashi H, Misaki Y, Mimori T, Muro Y, Yazawa N, Sato S, Takehara K, Kuwana M: Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. Rheumatology (Oxford). 2009, 48: 1570-1574. 10.1093/rheumatology/kep290.CrossRef
9.
go back to reference Satoh M, Chan EK, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, Mansoor R, Reeves WH: Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol. 2007, 3: 721-738. 10.1586/1744666X.3.5.721.CrossRefPubMed Satoh M, Chan EK, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, Mansoor R, Reeves WH: Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol. 2007, 3: 721-738. 10.1586/1744666X.3.5.721.CrossRefPubMed
10.
go back to reference Reveille JD, Solomon DH: Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003, 49: 399-412. 10.1002/art.11113.CrossRefPubMed Reveille JD, Solomon DH: Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003, 49: 399-412. 10.1002/art.11113.CrossRefPubMed
11.
go back to reference Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA: A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum. 2003, 48: 203-209. 10.1002/art.10760.CrossRefPubMed Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA: A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum. 2003, 48: 203-209. 10.1002/art.10760.CrossRefPubMed
12.
go back to reference Harvey GR, Butts S, Rands AL, Patel Y, McHugh NJ: Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis. Clin Exp Immunol. 1999, 117: 395-402. 10.1046/j.1365-2249.1999.00964.x.PubMedCentralCrossRefPubMed Harvey GR, Butts S, Rands AL, Patel Y, McHugh NJ: Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis. Clin Exp Immunol. 1999, 117: 395-402. 10.1046/j.1365-2249.1999.00964.x.PubMedCentralCrossRefPubMed
13.
go back to reference Ceribelli A, Cavazzana I, Franceschini F, Airo P, Tincani A, Cattaneo R, Pauley BA, Chan EK, Satoh M: Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. J Rheumatol. 2010, 37: 2071-2075. 10.3899/jrheum.100316.CrossRefPubMed Ceribelli A, Cavazzana I, Franceschini F, Airo P, Tincani A, Cattaneo R, Pauley BA, Chan EK, Satoh M: Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. J Rheumatol. 2010, 37: 2071-2075. 10.3899/jrheum.100316.CrossRefPubMed
14.
go back to reference Villalta D, Morozzi G, Tampoia M, Alpini C, Brusca I, Salgarolo V, Papisch W, Bizzaro N: Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis. Clin Chim Acta. 2010, 411: 710-713. 10.1016/j.cca.2010.01.037.CrossRefPubMed Villalta D, Morozzi G, Tampoia M, Alpini C, Brusca I, Salgarolo V, Papisch W, Bizzaro N: Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis. Clin Chim Acta. 2010, 411: 710-713. 10.1016/j.cca.2010.01.037.CrossRefPubMed
15.
go back to reference Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M: Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum. 2006, 54: 2004-2009. 10.1002/art.21883.CrossRefPubMed Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M: Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum. 2006, 54: 2004-2009. 10.1002/art.21883.CrossRefPubMed
16.
go back to reference Satoh M, Akizuki M, Yamagata H, Nakayama S, Homma M: Restricted heterogeneity and changing spectrotypes in autoantibodies to La/SS-B. Autoimmunity. 1996, 24: 229-236. 10.3109/08916939608994715.CrossRefPubMed Satoh M, Akizuki M, Yamagata H, Nakayama S, Homma M: Restricted heterogeneity and changing spectrotypes in autoantibodies to La/SS-B. Autoimmunity. 1996, 24: 229-236. 10.3109/08916939608994715.CrossRefPubMed
17.
go back to reference Okano Y, Medsger TA: Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA. J Immunol. 1992, 149: 1093-1098.PubMed Okano Y, Medsger TA: Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA. J Immunol. 1992, 149: 1093-1098.PubMed
18.
go back to reference Okano Y, Medsger TA: Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum. 1990, 33: 1822-1828. 10.1002/art.1780331210.CrossRefPubMed Okano Y, Medsger TA: Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum. 1990, 33: 1822-1828. 10.1002/art.1780331210.CrossRefPubMed
19.
go back to reference Kufel J, Allmang C, Chanfreau G, Petfalski E, Lafontaine DL, Tollervey D: Precursors to the U3 small nucleolar RNA lack small nucleolar RNP proteins but are stabilized by La binding. Mol Cell Biol. 2000, 20: 5415-5424. 10.1128/MCB.20.15.5415-5424.2000.PubMedCentralCrossRefPubMed Kufel J, Allmang C, Chanfreau G, Petfalski E, Lafontaine DL, Tollervey D: Precursors to the U3 small nucleolar RNA lack small nucleolar RNP proteins but are stabilized by La binding. Mol Cell Biol. 2000, 20: 5415-5424. 10.1128/MCB.20.15.5415-5424.2000.PubMedCentralCrossRefPubMed
20.
go back to reference Okano Y, Steen VD, Medsger TA: Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993, 119: 1005-1013.CrossRefPubMed Okano Y, Steen VD, Medsger TA: Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993, 119: 1005-1013.CrossRefPubMed
21.
go back to reference Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA: Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum. 2009, 60: 1112-1118. 10.1002/art.24409.CrossRefPubMed Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA: Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum. 2009, 60: 1112-1118. 10.1002/art.24409.CrossRefPubMed
22.
go back to reference Hashimoto C, Steitz JA: Sequential association of nucleolar 7-2 RNA with two different autoantigens. J Biol Chem. 1983, 258: 1379-1382.PubMed Hashimoto C, Steitz JA: Sequential association of nucleolar 7-2 RNA with two different autoantigens. J Biol Chem. 1983, 258: 1379-1382.PubMed
23.
go back to reference Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EK, Bubb MR, Sobel ES, Reeves WH, Satoh M: Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol. 2011, 30: 1333-1339. 10.1007/s10067-011-1751-0.PubMedCentralCrossRefPubMed Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EK, Bubb MR, Sobel ES, Reeves WH, Satoh M: Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol. 2011, 30: 1333-1339. 10.1007/s10067-011-1751-0.PubMedCentralCrossRefPubMed
24.
go back to reference Targoff IN, Arnett FC, Reichlin M: Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum. 1988, 31: 515-524. 10.1002/art.1780310408.CrossRefPubMed Targoff IN, Arnett FC, Reichlin M: Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum. 1988, 31: 515-524. 10.1002/art.1780310408.CrossRefPubMed
25.
go back to reference Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, Casciola-Rosen L, Hong G, Dellaripa PF, Highland KB: Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest. 2009, 135: 1550-1556. 10.1378/chest.08-2233.CrossRefPubMed Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, Casciola-Rosen L, Hong G, Dellaripa PF, Highland KB: Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest. 2009, 135: 1550-1556. 10.1378/chest.08-2233.CrossRefPubMed
26.
go back to reference Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN: Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007, 56: 1295-1303. 10.1002/art.22506.CrossRefPubMed Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN: Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007, 56: 1295-1303. 10.1002/art.22506.CrossRefPubMed
Metadata
Title
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis
Authors
Angela Ceribelli
Minoru Satoh
Edward KL Chan
Publication date
01-06-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3858

Other articles of this Issue 3/2012

Arthritis Research & Therapy 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine